Yasuyuki Kojima Selected Research

Antiemetics

1/2021

Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuyuki Kojima Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 07/2022 - 06/2008
20	Neoplasms (Cancer) 05/2021 - 10/2003
5	Triple Negative Breast Neoplasms 09/2021 - 01/2016
4	Neoplasm Metastasis (Metastasis) 07/2020 - 02/2015
3	Carcinoma (Carcinomatosis) 07/2022 - 01/2008
3	Hypertension (High Blood Pressure) 12/2011 - 08/2008
2	Lymphatic Metastasis 01/2022 - 01/2020
2	Meningeal Carcinomatosis 07/2020 - 07/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2011 - 10/2003
2	Adenocarcinoma 01/2010 - 10/2005
1	Hypersensitivity (Allergy) 09/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2021
1	Pathologic Complete Response 05/2021
1	Anorexia 01/2021
1	Nausea 01/2021
1	Fatigue 01/2021
1	Vomiting 01/2021
1	Sleepiness 01/2021
1	Brain Neoplasms (Brain Tumor) 07/2020
1	Cardiotoxicity 12/2019
1	Fibroadenoma 07/2015
1	Leiomyoma (Uterine Fibroids) 07/2015
1	Proteinuria 12/2011
1	Albuminuria 12/2011
1	Stomach Neoplasms (Stomach Cancer) 01/2010
1	Anuria 01/2010
1	Adenoma (Adenomas) 01/2010
1	Hyperaldosteronism (Conn Syndrome) 01/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2010

Drug/Important Bio-Agent (IBA)

7	human ERBB2 proteinIBA 09/2021 - 09/2016
6	taxaneIBA 09/2021 - 09/2016
5	Trastuzumab (Herceptin)FDA Link 05/2020 - 09/2016
4	AnthracyclinesIBA 01/2021 - 09/2016
3	Phenobarbital (Luminal)FDA Link 09/2021 - 01/2016
3	eribulin FDA Link 05/2020 - 10/2019
3	Estrogen ReceptorsIBA 01/2020 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 08/2008
2	Ethanol (Ethyl Alcohol)IBA 09/2021 - 10/2003
2	Albumin-Bound Paclitaxel FDA Link 09/2021 - 10/2018
2	ErbB Receptors (EGF Receptor)IBA 05/2021 - 12/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2018
2	Hormones (Hormone)IBA 11/2020 - 09/2009
2	pertuzumabIBA 05/2020 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 10/2018
2	Cadherins (E-Cadherin)IBA 09/2014 - 01/2010
2	PKC-3 proteinIBA 09/2014 - 09/2009
2	PotassiumIBA 12/2011 - 01/2010
2	CreatinineIBA 12/2011 - 11/2003
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 06/2008
2	protein kinase C lambdaIBA 01/2010 - 06/2008
1	cremophorIBA 09/2021
1	AntiemeticsIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Drug CombinationsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Olanzapine (Zyprexa)FDA Link 01/2021
1	SteroidsIBA 01/2021
1	Aprepitant (Emend)FDA Link 01/2021
1	Palonosetron (Aloxi)FDA Link 01/2021
1	Epidermal Growth Factor (EGF)IBA 05/2020
1	Genetic Markers (Genetic Marker)IBA 12/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Capecitabine (Xeloda)FDA Link 01/2019
1	Ado-Trastuzumab EmtansineIBA 01/2019
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2018
1	AlbuminsIBA 10/2018
1	Epirubicin (Ellence)FDA LinkGeneric 10/2018
1	130-nm albumin-bound paclitaxelIBA 10/2018
1	Docetaxel (Taxotere)FDA Link 09/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	olaparibIBA 08/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2015
1	Histone Deacetylase InhibitorsIBA 08/2015
1	Mediator ComplexIBA 07/2015
1	Gemcitabine FDA Link 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	CateninsIBA 09/2014
1	Collagen Type IV (Type IV Collagen)IBA 09/2014
1	Angiotensin IIIBA 12/2011
1	ReninIBA 12/2011
1	Hemoglobins (Hemoglobin)IBA 12/2011
1	candesartanIBA 12/2011
1	AldosteroneIBA 01/2010
1	Indicators and Reagents (Reagents)IBA 01/2010

Therapy/Procedure

7	Neoadjuvant Therapy 09/2021 - 01/2016
4	Therapeutics 07/2022 - 02/2015
3	Radiotherapy 01/2022 - 07/2020
3	Drug Therapy (Chemotherapy) 01/2021 - 02/2015
2	Adjuvant Chemotherapy 01/2020 - 02/2015
2	Kidney Transplantation 02/2015 - 08/2008
2	Transplantation 08/2008 - 10/2003
1	Aftercare (After-Treatment) 03/2022
1	Mastectomy (Mammectomy) 11/2016
1	Skin Transplantation (Skin Grafting) 07/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	TP protocol 02/2015
1	Combination Drug Therapy (Combination Chemotherapy) 02/2015
1	Nephrectomy 11/2011
1	Gastrectomy 01/2010
1	Adrenalectomy 01/2010